Showing results (221-230 of 530) with videos related to

Sort By:
Pageof 53
European Heart Journal. Cardiovascular Pharmacotherapy|August 12, 2025
Impact of left ventricular ejection fraction on the effect of beta-blocker therapy on one-year mortality in acute coronary syndrome patientsMicha T Maeder, Fabienne Foster-Witassek, Dragana Radovanovic, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|February 16, 2026
A Bayesian analysis of finerenone in heart failure with mildly reduced and preserved ejection fraction: a pre-specified analysis of FINEARTS-HFAlasdair D Henderson, Kieran F Docherty, Atefeh Talebi, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|January 30, 2023
Prasugrel dose de-escalation in diabetic patients with acute coronary syndrome receiving percutaneous coronary intervention: results from the HOST-REDUCE-POLYTECH-ACS trialKyu-Sun Lee, Keun-Ho Park, Kyung Woo Park, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|March 7, 2024
GPVI inhibition: Advancing antithrombotic therapy in cardiovascular diseaseAlexandre Slater, Sophia Khattak, Mark R Thomas
European Heart Journal. Cardiovascular Pharmacotherapy|July 27, 2023
The effect of SGLT2 inhibitors on the endothelium and the microcirculation: from bench to bedside and beyondKyriakos Dimitriadis, Eleni Adamopoulou, Nikolaos Pyrpyris, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|August 10, 2023
Bioinformatic platforms for clinical stratification of natural history of atherosclerotic cardiovascular diseasesGiuditta Benincasa, Rosa Suades, Teresa Padró, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|May 30, 2023
A gene risk score using missense variants in SLCO1B1 is associated with earlier onset statin intoleranceMargherita Bigossi, Cyrielle Maroteau, Adem Y Dawed, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|April 17, 2024
Glucagon-like peptide-1 receptor agonists use and associations with outcomes in heart failure and type 2 diabetes: data from the Swedish Heart Failure and Swedish National Diabetes RegistriesMarkus Wallner, Mattia Emanuele Biber, Davide Stolfo, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|April 11, 2024
Safety and effectiveness of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: insights from the SPUM-ACS studyFrancesco Bruno, Florian A Wenzl, Ovidio De Filippo, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|August 31, 2023
Characteristics and outcomes in patients with a prior myocardial infarction treated with extended dual antiplatelet therapy with ticagrelor 60 mg: findings from ALETHEIA, a multi-country observational studyM P Bonaca, E Lesén, E Giannitsis, et al.
Pageof 53